Last reviewed · How we verify
NCT04691479: PIMA1-JO-PR
Adherence and Quality of Life of CPAP for Obstructive Sleep Apnea
NA trial testing Motivational Interview (MI) & Adherence Follow-Up in Sleep Apnea, Obstructive in 129 participants. Completed in 20 November 2018.
11 September 2018
Quick facts
| Lead sponsor | Air Liquide Healthcare Spain |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 129 |
| Start date | 10 March 2018 |
| Primary completion | 11 September 2018 |
| Estimated completion | 20 November 2018 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Motivational Interview (MI) & Adherence Follow-Up
- Adherence Follow-Up
Conditions studied
- Sleep Apnea, Obstructive — all drugs for Sleep Apnea, Obstructive →
Sponsor
Air Liquide Healthcare Spain — full company profile →
Who can join
18 and older, any sex, with Sleep Apnea, Obstructive. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A multicentre, randomized controlled trial (RCT) design.The control group followed the usual treatment, while the intervention group (PIMA) followed the treatment with an adapted and flexible care plan depending on socio-demographic, clinical and psychological variables. The treatment plan includes different channels (home, telephone, care center), a continuous evaluation, and the use of the motivational interview in each of the interventions with the patient. The main outcome was adherence. Secondary outcomes were quality of life, emotional state, activities, social relationships, perceived competence and motivation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04691479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motivational Interview (MI) & Adherence Follow-Up
Trials testing the same drug.
- NCT04650061 — PIMA - Individualized Adherence Improvement Plan · NA · unknown
Other recruiting trials for Sleep Apnea, Obstructive
Currently open trials in the same condition.
- NCT06828835 — The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention · NA · recruiting
- NCT06915831 — Type 1 Diabetes and Obstructive Sleep Apnea · NA · recruiting
- NCT07176767 — The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents · recruiting
- NCT06573372 — Evaluating the Diagnostic Efficacy of Smartwatch and Smartphone for Sleep Apnea · recruiting
- NCT06848647 — Treatment of Sleep Apnea to Improve Metabolic Health · recruiting
Other Air Liquide Healthcare Spain trials
Trials by the same sponsor.
- NCT04650061 — PIMA - Individualized Adherence Improvement Plan · NA · unknown
- NCT07258264 — MEntA Program Based on Motivational Interview to Improve Adherence to Treatment of Obstructive Sleep Apnea With Continuo · NA · completed
- NCT04691336 — Individualized Plan for Improving Adherence to Portable Oxygen Therapy in Patients With Respiratory Pathology · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04691479 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Air Liquide Healthcare Spain
- Last refreshed: 31 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04691479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing